When to Order Urine Organic Acid Panel in Adults
Order urine organic acid analysis in adults when there is clinical suspicion for inborn errors of metabolism based on specific symptoms or laboratory abnormalities, as these disorders can present for the first time at any age, not just in childhood. 1
Clinical Indications for Testing
The 2018 ACMG guidelines explicitly state that clinical symptoms of organic acidurias "can occur for the first time at any age from the neonatal period to adulthood." 1 This is critical—do not assume metabolic disorders only present in children.
Specific Clinical Scenarios Warranting Testing:
Neurological presentations:
- Unexplained encephalopathy or altered mental status
- Progressive neurological deterioration
- Movement disorders
- Unexplained seizures
- Exercise intolerance with muscle weakness 2
Metabolic decompensation:
- Unexplained metabolic acidosis (particularly with elevated anion gap)
- Recurrent episodes of vomiting and lethargy
- Hyperammonemia without clear cause
- Hypoglycemia with ketosis
- Lactic acidosis 3
Organ-specific findings:
- Hepatomegaly with fatty liver on biopsy 2
- Recurrent pancreatitis (documented in adult-onset glutaric aciduria type II) 2
- Cardiomyopathy
- Unexplained chronic kidney disease 4
Urological presentations:
- Recurrent nephrolithiasis (especially calcium oxalate stones)
- Nephrocalcinosis with declining GFR
- Oxalate crystals in urine or tissue 4
Key Laboratory Triggers:
Order testing when you see:
- Elevated anion gap metabolic acidosis
- Hyperammonemia
- Elevated creatine kinase
- Abnormal newborn screening in family members
- Positive family history of metabolic disease 1
Optimal Timing and Collection
Collect urine during acute illness or metabolic decompensation whenever possible—diagnostic metabolites are highest during these states. 1 If the patient is stable, a random urine sample is acceptable, but the diagnostic yield may be lower.
Collection requirements:
- 1-5 mL urine in clean container without preservatives
- Freeze immediately after collection
- Ship on dry ice if sending to reference lab
- Samples stable for years at -20°C 1
Critical Pitfalls to Avoid
Do not dismiss the possibility of metabolic disease based on:
- Normal newborn screening (this is NOT diagnostic testing) 1
- Adult age at presentation 1
- Mild or intermittent symptoms
Be aware of confounding factors that can alter results:
- Medications: Valproate, acetaminophen, ibuprofen, aspirin, levetiracetam can produce abnormal peaks or elevate specific organic acids 1
- Diet: Ketogenic diet, MCT oil, TPN, gelatin 1
- Nutritional status: B12/folate deficiency can cause mild methylmalonic acid elevation 1
- Bacterial contamination: Prolonged storage at room temperature 1
Always provide clinical context to the laboratory including:
- Clinical indication for testing
- Patient's clinical state (acute vs. stable)
- Current medications and diet
- Contact information for urgent results 1
Complementary Testing
Order concurrently with organic acid analysis:
- Plasma amino acids
- Acylcarnitine profile
- Free and total carnitine 1
Ideally, send all samples to the same laboratory for integrated interpretation. 1
Special Populations
Kidney transplant recipients: Consider testing if they have:
- Previous CKD of unknown etiology
- History of recurrent urolithiasis
- Graft nephrocalcinosis with declining GFR without other clear cause 4
Adults with recurrent urolithiasis: While routine screening of all adults with hyperoxaluria is not cost-effective, test when clinical criteria suggest primary hyperoxaluria (recurrent stones, nephrocalcinosis, oxalate crystals). 4
Interpretation Considerations
Results must be interpreted by board-certified laboratory directors with expertise in biochemical genetics. 1 Diagnosis relies on pattern recognition of multiple metabolites, not isolated abnormalities. Some patients with confirmed disorders may have normal or near-normal results when clinically stable (e.g., "low excretors" in glutaric acidemia type I). 1
The diagnostic sensitivity varies considerably based on the patient's metabolic state, residual enzyme activity, and dietary precursor load at the time of collection. 1